GTS Securities LLC decreased its position in UiPath Inc. (NYSE:PATH - Free Report) by 87.0% in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 41,323 shares of the company's stock after selling 276,642 shares during the quarter. GTS Securities LLC's holdings in UiPath were worth $525,000 as of its most recent filing with the SEC.
Other large investors have also recently added to or reduced their stakes in the company. Smartleaf Asset Management LLC boosted its position in shares of UiPath by 88.5% in the fourth quarter. Smartleaf Asset Management LLC now owns 2,454 shares of the company's stock valued at $31,000 after acquiring an additional 1,152 shares during the period. First Horizon Advisors Inc. boosted its position in shares of UiPath by 47.8% in the fourth quarter. First Horizon Advisors Inc. now owns 2,487 shares of the company's stock valued at $32,000 after acquiring an additional 804 shares during the period. EverSource Wealth Advisors LLC boosted its position in shares of UiPath by 141.4% in the fourth quarter. EverSource Wealth Advisors LLC now owns 2,974 shares of the company's stock valued at $38,000 after acquiring an additional 1,742 shares during the period. V Square Quantitative Management LLC boosted its position in shares of UiPath by 33.4% in the fourth quarter. V Square Quantitative Management LLC now owns 3,030 shares of the company's stock valued at $39,000 after acquiring an additional 759 shares during the period. Finally, Harvest Fund Management Co. Ltd bought a new stake in shares of UiPath in the fourth quarter valued at approximately $50,000. Institutional investors own 62.50% of the company's stock.
UiPath Price Performance
Shares of PATH stock traded up $0.02 during trading hours on Thursday, hitting $12.96. 27,011,856 shares of the company's stock were exchanged, compared to its average volume of 10,996,258. The stock's 50-day moving average is $11.46 and its 200-day moving average is $12.70. The stock has a market cap of $7.15 billion, a price-to-earnings ratio of -80.98 and a beta of 1.01. UiPath Inc. has a 52 week low of $9.38 and a 52 week high of $18.63.
UiPath (NYSE:PATH - Get Free Report) last announced its earnings results on Thursday, May 29th. The company reported ($0.02) EPS for the quarter, missing the consensus estimate of $0.10 by ($0.12). UiPath had a negative return on equity of 4.14% and a negative net margin of 6.49%. Equities research analysts forecast that UiPath Inc. will post -0.17 earnings per share for the current fiscal year.
Insider Buying and Selling
In other UiPath news, CFO Ashim Gupta sold 98,795 shares of the stock in a transaction dated Thursday, May 1st. The stock was sold at an average price of $12.01, for a total value of $1,186,527.95. Following the transaction, the chief financial officer now owns 987,322 shares of the company's stock, valued at approximately $11,857,737.22. This represents a 9.10% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, CAO Hitesh Ramani sold 12,500 shares of the firm's stock in a transaction dated Thursday, April 3rd. The stock was sold at an average price of $10.19, for a total value of $127,375.00. Following the transaction, the chief accounting officer now owns 314,891 shares in the company, valued at approximately $3,208,739.29. This trade represents a 3.82% decrease in their position. The disclosure for this sale can be found here. Corporate insiders own 23.19% of the company's stock.
Analysts Set New Price Targets
Several research firms have recently weighed in on PATH. UBS Group reduced their price objective on UiPath from $14.00 to $10.00 and set a "sell" rating for the company in a research report on Thursday, March 13th. Canaccord Genuity Group reduced their price objective on UiPath from $19.00 to $14.00 and set a "buy" rating for the company in a research report on Thursday, March 13th. Mizuho cut their target price on UiPath from $12.00 to $11.00 and set a "neutral" rating for the company in a research note on Tuesday, April 15th. Morgan Stanley cut their target price on UiPath from $16.00 to $12.00 and set an "equal weight" rating for the company in a research note on Thursday, March 13th. Finally, Royal Bank of Canada restated a "sector perform" rating and issued a $13.00 target price on shares of UiPath in a research note on Wednesday, March 26th. Two research analysts have rated the stock with a sell rating, fifteen have assigned a hold rating and two have issued a buy rating to the company's stock. According to data from MarketBeat, the company has a consensus rating of "Hold" and an average target price of $12.72.
Read Our Latest Analysis on PATH
UiPath Company Profile
(
Free Report)
UiPath Inc provides an end-to-end automation platform that offers a range of robotic process automation (RPA) solutions primarily in the United States, Romania, the United Kingdom, the Netherlands, and internationally. The company offers a suite of interrelated software to build, manage, run, engage, measure, and govern automation within the organization.
Featured Articles

Before you consider UiPath, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and UiPath wasn't on the list.
While UiPath currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.